Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw

International Journal of Oral and Maxillofacial Surgery

Volumn 41, Issue 11, 2012, Pages 1410-1415

  Bocanegra Perez S ^a   Vicente Barrero, M ^a,b   Knezevic, M ^a   Castellano Navarro, J M ^a   Rodriguez Bocanegra E ^a   Rodriguez Millares J ^a   Perez Plasencia D ^a   Ramos Macias A ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b NONE   (Spain)

Author keywords

alendronate; bisphosphonates; jaw; osteonecrosis; pamidronate; platelet rich plasma; treatment; zoledronate

Indexed keywords

ALENDRONIC ACID; ALENDRONIC ACID PLUS COLECALCIFEROL; CLODRONIC ACID; PAMIDRONIC ACID; THROMBOCYTE CONCENTRATE; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEBRIDEMENT; FEMALE; FOLLOW UP; HUMAN; JAW OSTEONECROSIS; MALE; THROMBOCYTE RICH PLASMA;

EID: 84867395988     PISSN: 09015027     EISSN: 13990020     Source Type: Journal    
DOI: 10.1016/j.ijom.2012.04.020     Document Type: Article

References (30)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117
2. G.D. Carter, and A.N. Gross Bisphosphonates and avascular necrosis of the jaws Aust Dent J 48 2003 268 273
3. S.L. Ruggiero, B. Mehrotra, T.J. Rosenberg, and S.L. Engroff Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases J Oral Maxillofac Surg 62 2004 527 534
4. J.W. Hellstein, and C.L. Marek Bisphosphonate osteochemonecrosis (Bis-Phossy Jaw): is this phossy jaw of the 21st century J Oral Maxillofac Surg 63 2005 682 689
5. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws J Oral Maxillofac Surg 65 2007 369 376
6. C.A. Migliorati, J. Casiglia, J. Epstein, P.L. Jacobsen, M.A. Siegel, and S.B. Woo Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine Position Paper JADA 136 2005 1658
7. R.E. Marx Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws J Oral Maxillofac Surg 67 2009 107 119
8. N. Yarom, S. Elad, C. Madrid, and C.A. Migliorati Osteonecrosis of the jaws induced by drugs other than bisphosphonates - a call to update terminology in light of new data Oral Oncol 46 2010 1
9. M.C. Adornato, I. Morcos, and J. Rozanski The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors J Am Dent Assoc 138 2007 971 977
10. C.Y. Lee, T. David, and M. Nishime Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: a report of 2 cases J Oral Implantol 33 2007 371 382
11. M.M. Curi, G.S. Cossolin, D.H. Koga, S.R. Araújo, O. Feher, and M.O. dos Santos Treatment of avascular osteonecrosis of the jaw in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases J Oral Maxillofac Surg 65 2007 349 355
12. D.M. Dohan Ehrenfest, L. Rasmusson, and T. Albrektsson Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leukocyte- and platelet-rich fibrin (L-PRF) Trends Biotechnol 27 2009 158 167
13. R.E. Marx Platelet-rich plasma: evidence to support its use J Oral Maxillofac Surg 62 2004 489 496
14. R. Oliver Bisphosphonates and oral surgery Oral Surg 2009 56 63
15. M. Tischler Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts N Y State Dent J 68 2002 22 24
16. J.V. Bagán, Y. Jimenez, J.M. Diaz, J. Murillo, J.M. Sanchis, and R. Poveda Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification Oral Oncol 45 2009 645 646
17. R.E. Marx, E.R. Carlson, R.M. Eichstaedt, S.R. Schimmele, J.E. Strauss, and K.R. Georgeff Platelet-rich plasma: Growth factor enhancement for bone grafts Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 1998 638 646
18. S.V. Kevy, and M.S. Jacobson Comparison of methods for point of care preparation of autologous platelet gel J Extra Corpor Technol 36 2004 28 35
19. I. Reid Pathogenesis of osteonecrosis of the Jaw IBMS Bonekey 2 2008 69 77
20. C.A. Migliorati, M.M. Schubert, D.E. Peterson, and L.M. Seneda Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy Cancer 104 2005 83 93
21. L. Montebugnoli, L. Felicetti, D.B. Gissi, A. Pizzigallo, G.A. Pelliccioni, and C. Marchetti Bisphosphonate-associated osteonecrosis can be controlled by nonsurgical management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 2007 473 477
22. M.R. Markiewicz, J.E. Margarone 3rd, J.H. Campbell, and A. Aguirre Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge J Am Dent Assoc 136 2005 1669 1674
23. H. Goto, T. Matsuyama, M. Miyamoto, Y. Yonamine, and Y. Izumi Platelet-rich plasma/osteoblasts complex induces bone formation via osteoblastic differentiation following subcutaneous transplantation J Periodontal Res 41 2006 455 462
24. M. Scoletta, P.G. Arduino, R. Pol, V. Arata, S. Silvestri, and A. Chiecchio Initial experience on the outcome of teeth extractions in intravenous bisphosphonate-treated patients: a cautionary report J Oral Maxillofac Surg 69 2011 456 462
25. K. Yokota, O. Ishida, T. Sunagawa, O. Suzuki, A. Nakamae, and M. Ochi Platelet-rich plasma accelerated surgical angio-genesis in vascular-implanted necrotic bone: an experimental study in rabbits Acta Orthop 79 2008 106 110
26. J.M. Martínez-González, J. Cano-Sánchez, J.C. Gonzalo-Lafuente, J. Campo-Trapero, G. Esparza-Gomez, and J. Seoane Do ambulatory-use platelet-rich plasma (PRP) concentrates present risks? Med Oral 7 2002 375 390
27. S.E. Lynch, G.R. de Castilla, R.C. Williams, C.P. Kiritsy, T.H. Howell, and M.S. Reddy The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing J Periodontol 62 1991 458 467
28. S. Cetiner, G.T. Sucak, S.A. Kahraman, S.Z. Aki, B. Kocakahyaoglu, and S.E. Gultekin Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid J Bone Miner Metab 27 2009 435 443
29. E. Vairaktaris, S. Vassiliou, D. Avgoustidis, P. Stathopoulos, T. Toyoshima, and C. Yapijakis Bisphosphonate-induced avascular osteonecrosis of the jaw associated with a common thrombophilic mutation in the prothrombin gene J Oral Maxillofac Surg 67 2009 2009 2012
30. M.S. Badr, and R.J. Oliver Platelet-rich plasma: an adjunctive treatment modality for bisphosphonate osteonecrosis? J Oral Maxillofac Surg 67 2009 1357 Comment on: J Oral Maxillofac Surg 2007;65:349-55